Filter Results:
(219)
Show Results For
- All HBS Web
(473)
- News (132)
- Research (219)
- Multimedia (8)
- Faculty Publications (136)
Show Results For
- All HBS Web
(473)
- News (132)
- Research (219)
- Multimedia (8)
- Faculty Publications (136)
Sort by
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Relationships Authors:Robin Ely and Laura Morgan Roberts Publication:In Diversity at Work, edited by Arthur P. Brief. Cambridge University Press, forthcoming Abstract No abstract available. Exploring Black... View Details
Keywords: Martha Lagace
- April 2011
- Supplement
U.S. Healthcare Reform: International Perspectives (PPT)
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "U.S. Healthcare Reform: International Perspectives (PPT)." Harvard Business School PowerPoint Supplement 711-105, April 2011.
- December 2010
- Supplement
Targanta Therapeutics: Hitting a Moving Target (PPT)
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target (PPT)." Harvard Business School PowerPoint Supplement 711-056, December 2010.
- November 2009 (Revised December 2010)
- Supplement
International Lobbying and The Dow Chemical Company (B): Regulatory Reform in the USA?
By: Arthur A. Daemmrich
Keywords: Governing Rules, Regulations, and Reforms; Government and Politics; Chemical Industry; United States
Daemmrich, Arthur A. "International Lobbying and The Dow Chemical Company (B): Regulatory Reform in the USA?" Harvard Business School Supplement 710-028, November 2009. (Revised December 2010.)
- July 2009
- Teaching Note
Targanta Therapeutics: Hitting a Moving Target (TN)
By: Arthur A. Daemmrich
Teaching Note for [709002]. View Details
- fall 2007
- Article
Pharmaceutical Regulation in the United States and Europe
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Pharmaceutical Regulation in the United States and Europe." Focus on Law Studies 23, no. 1 (fall 2007): 8–11.
- 2004
- Book
Pharmacopolitics: Drug Regulation in the United States and Germany
By: Arthur A. Daemmrich
Keywords: Health; Governing Rules, Regulations, and Reforms; Government and Politics; United States; Germany
Daemmrich, Arthur A. Pharmacopolitics: Drug Regulation in the United States and Germany. University of North Carolina Press, 2004. (Winner of Edward Kremers Award of the American Institute of the History of Pharmacy For best book in pharmaco-historical writing published in the previous two years presented by American Institute of the History of Pharmacy.)
- October – December 1998
- Article
The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies." Special Issue on Contested Identities: Science, Law and Forensic Practice. Social Studies of Science 28, nos. 5/6 (October–December 1998): 741–772.
- April 2002
- Article
A Tale of Two Experts: Thalidomide and Political Engagement in the United States and West Germany
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "A Tale of Two Experts: Thalidomide and Political Engagement in the United States and West Germany." Social History of Medicine 15, no. 1 (April 2002): 137–158.
- March 2011
- Teaching Note
International Lobbying and the Dow Chemical Company (TN) (A) & (B)
By: Arthur A. Daemmrich
Teaching Note for 710027 and 710028. View Details
- July 2009 (Revised June 2012)
- Teaching Note
Denmark: Globalization and the Welfare State (TN)
By: Arthur A. Daemmrich
Teaching Note for [709015]. View Details
- November 2008 (Revised July 2009)
- Background Note
A Managerial Perspective on Clinical Trials
By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
- 2003
- Chapter
Regulatory Laws and Political Culture in the United States and Germany
By: Arthur A. Daemmrich
- 2003
- Chapter
La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971
By: Arthur A. Daemmrich
- 2006
- Chapter
BioRisk: interleukin-2 from laboratory to market in the United States and Germany
By: Arthur A. Daemmrich
- June 2016 (Revised February 2017)
- Case
The Role of Real Estate in Endowment Portfolios: The Case of Christ Church, Oxford
By: David Chambers, Elroy Dimson, Arthur I Segel and Eva Steiner
The case centers on Christ Church's Treasurer, James Lawrie, who is contemplating his options for investing a portion of the College's endowment in real estate. Approximately 1/3 of the total $690 million endowment was allocated towards real estate, much higher than... View Details
Keywords: Real Estate; Endowment Management; Endowments; United Kingdom; Oxford; Portfolio Allocation; Higher Education; Investment Portfolio; Property; Corporate Finance; Financial Services Industry; United Kingdom
Chambers, David, Elroy Dimson, Arthur I Segel, and Eva Steiner. "The Role of Real Estate in Endowment Portfolios: The Case of Christ Church, Oxford." Harvard Business School Case 216-086, June 2016. (Revised February 2017.)
- October 2012
- Teaching Note
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich
- December 2010
- Supplement
Denmark: Globalization and the Welfare State (PPT)
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Denmark: Globalization and the Welfare State (PPT)." Harvard Business School PowerPoint Supplement 711-057, December 2010.
- December 2010 (Revised April 2012)
- Background Note
Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round
By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details
Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
- January 2009 (Revised July 2009)
- Case
Targanta Therapeutics: Hitting a Moving Target
By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)